In the latest trading session,, 0.46 million CureVac N.V (NASDAQ:CVAC) shares changed hands as the company’s beta touched 2.41. With the company’s most recent per share price at $4.17 changing hands around $0.3 or 7.75% at last look, the market valuation stands at $938.90M. CVAC’s current price is a discount, trading about -26.62% off its 52-week high of $5.28. The share price had its 52-week low at $2.37, which suggests the last value was 43.17% up since then. When we look at CureVac N.V’s average trading volume, we note the 10-day average is 0.6 million shares, with the 3-month average coming to 617.09K.
Analysts gave the CureVac N.V (CVAC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CVAC as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
CureVac N.V (NASDAQ:CVAC) trade information
Instantly CVAC is in green as seen in intraday trades today. With action 22.83%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 22.29%, with the 5-day performance at 22.83% in the green. However, in the 30-day time frame, CureVac N.V (NASDAQ:CVAC) is 29.91% up. Looking at the short shares, we see there were 4.99 million shares sold at short interest cover period of 7.87 days.
The consensus price target for the stock as assigned by Wall Street analysts is 29, meaning bulls need an upside of 85.62% from its recent market value. According to analyst projections, CVAC’s forecast low is 21 with 37 as the target high. To hit the forecast high, the stock’s price needs a -787.29% plunge from its current level, while the stock would need to soar -403.6% for it to hit the projected low.
The 2025 estimates are for CureVac N.V earnings to decrease by -163.55%.
CVAC Dividends
CureVac N.V is expected to release its next quarterly earnings report on 2025-Apr-10.
CureVac N.V (NASDAQ:CVAC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 57.44% of CureVac N.V shares while 4.60% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 10.82%. There are 4.60% institutions holding the CureVac N.V stock share, with MILLENNIUM MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 1.2808% of the shares, roughly 2.87 million CVAC shares worth $9.77 million.
POINT72 ASSET MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 1.0801% or 2.42 million shares worth $8.24 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Core MSCI EAFE ETF and iShares Trust-iShares Biotechnology ETF . With 652.13 shares estimated at $2.71 million under it, the former controlled 0.29% of total outstanding shares. On the other hand, iShares Trust-iShares Biotechnology ETF held about 0.27% of the shares, roughly 598.13 shares worth around $2.49 million.
